Clinical Trial to Assess the Preventive Effects of Cetylpyridinium Chloride on Sarcopenia
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
This study is to assess the impact on the prevention of sarcopenia after taking
cetylpyridinium chloride targeting the patients of pre-sarcopenia or sarcopenia over the age
of 60